Stocklytics Platform
Asset logo for symbol VTYX
Ventyx Biosciences
VTYX61
$1.70arrow_drop_down7.14%-$0.13
High Growth
Penny Stock
Asset logo for symbol VTYX
VTYX61

$1.70

arrow_drop_down7.14%
Key Stats
Open$1.80
Prev. Close$1.82
EPS-1.97
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$86.10M
PE Ratio-
LOWHIGH
Day Range1.65
1.87
52 Week Range0.88
30.20
Ratios
Revenue-
EBITDA Margin %-
EPS-1.97
Fundamentals
Gross Profit-
Payout Ratio-
Industry average yield2.89%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

VTYX-
US Healthcare Sector-
US Market-
warning

VTYX / Market

VTYX lose to the US Market which returned 0.03% over the last twenty four hours.
warning

VTYX / Healthcare Sector

VTYX lose to the US Healthcare sector which returned 2.60% over the last twenty four hours.

Ventyx Biosciences (VTYX) Statistics

Ventyx Biosciences, Inc. (VTYX) is a biotechnology company that specializes in developing innovative solutions for the healthcare industry. The company focuses on the research and development of advanced therapeutics and diagnostic tools that can significantly improve patient outcomes. With a strong commitment to innovation, Ventyx Biosciences is at the forefront of cutting-edge technologies and breakthrough discoveries in the field of biosciences.
When it comes to stock statistics, Ventyx Biosciences has shown impressive performance in the market. The stock has consistently outperformed its sector and has delivered strong returns for its investors. Its valuation metrics also indicate that the stock is undervalued, making it an attractive investment opportunity. In terms of fundamentals, Ventyx Biosciences has a solid financial foundation. The company has generated significant revenue per share, indicating its strong financial performance.
add Ventyx Biosciences to watchlist

Keep an eye on Ventyx Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Ventyx Biosciences (VTYX) stock's performance compared to its sector and the market over the past year?

Over the past year, Ventyx Biosciences (VTYX) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, Ventyx Biosciences has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights Ventyx Biosciences's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Ventyx Biosciences (VTYX) stock?

The PE ratio for Ventyx Biosciences (VTYX) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Ventyx Biosciences (VTYX) stock?

The Earnings Per Share (EPS) for Ventyx Biosciences (VTYX), calculated on a diluted basis, is -$1.97. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Ventyx Biosciences (VTYX) stock?

The operating margin for Ventyx Biosciences (VTYX) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Ventyx Biosciences (VTYX) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Ventyx Biosciences (VTYX) is -$148.18M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Ventyx Biosciences (VTYX) have?

Ventyx Biosciences (VTYX) has a total debt of $10.79M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$16.47M.

Take Your Investments to a Whole New Level